Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL202380 | 0.87 | ALDH1A1 (0.40) | ALDH1A1MEN1MAPTKMT2ALMNA | |
| SCHEMBL7202517 | 0.80 | LMNA (0.39) | ALDH1A1MEN1USP2TP53CYP3A4 | |
| SCHEMBL7709890 | 0.74 | ALDH1A1 (0.40) | ALDH1A1MEN1MAPTKMT2ALMNA | |
| SCHEMBL7203351 | 0.74 | GRIK1 (0.33) | — | |
| SCHEMBL315270 | 0.73 | TSHR (0.48) | ALDH1A1MEN1MAPTKMT2ALMNA | |
| SCHEMBL7704110 | 0.72 | TSHR (0.39) | ALDH1A1MAPTLMNAHSD17B10TSHR | |
| SCHEMBL10352883 | 0.72 | TSHR (0.39) | ALDH1A1MAPTMAPK1LMNAHSD17B10 | |
| SCHEMBL11101510 | 0.72 | TSHR (0.39) | ALDH1A1MAPTKMT2ALMNAHSD17B10 | |
| SCHEMBL1471664 | 0.72 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2ALMNAHSD17B10 | |
| SCHEMBL3030080 | 0.71 | TSHR (0.37) | ALDH1A1CYP3A4MAPTKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6607868-B2 | Dipropargyl acetamide | HYNIX SEMICONDUCTOR INC. (KR) | 2003-08-19 | — | — | US | disclosed |
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | CDH1, DDAH1, DPEP1 | ALDH1A1 67/4885MEN1 2541/4885USP2 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.